Evaluation of Superficial Basal Cell Carcinomas After Treatment With Imiquimod 5% Cream or Vehicle for Apoptosis and Lymphocyte Phenotyping

Caspases: the executioners of apoptosis

1997 • 4,674 citations

Type I Interferons Keep Activated T Cells Alive

1999 • 769 citations

Nonmelanoma Cancers of the Skin

1992 • 541 citations

Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream

1999 • 375 citations

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial

2001 • 351 citations

Treatment of genital warts with an immune-response modifier (imiquimod)

1998 • 308 citations

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study*

2002 • 286 citations

Cytokine induction by the immunomodulators imiquimod and S-27609

1995 • 268 citations

Mechanisms of Interferon-alpha induced apoptosis in malignant cells

2002 • 218 citations

Intralesional interferon therapy for basal cell carcinoma

1990 • 202 citations

Cytokine Induction in Hairless Mouse and Rat Skin After Topical Application of the Immune Response Modifiers Imiquimod and S-28463

1998 • 173 citations

Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms

2002 • 171 citations

Spontaneous regression of human melanoma/nonmelanoma skin cancer: Association with infiltrating CD4⁺ T cells

1995 • 146 citations

Regression in basal cell carcinoma: an immunohistochemical analysis

1994 • 124 citations

Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines.

1997 • 120 citations

Imiquimod 5% cream (Aldara™)

1998 • 115 citations

Cytokine profiles in spontaneously regressing basal cell carcinomas

2000 • 92 citations

Differential expression of the bcl-2 oncogene in human basal cell carcinoma

1996 • 81 citations

Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle

2003 • 79 citations

Guidelines of care for basal cell carcinoma

1992 • 79 citations

bcl‐2 protein expression in aggressive and non‐aggressive basal cell carcinomas

2000 • 67 citations

Guidelines of care for alopecia areata

1992 • 65 citations

Intralesional interferon alfa-2b in the treatment of basal cell carcinoma

1991 • 59 citations

p53 expression related to the aggressive infiltrative histopathological feature of basal cell carcinoma

2002 • 53 citations

Interferon-α-Mediated Prevention of in Vitro Apoptosis of Chronic Lymphocytic Leukemia B Cells: Role of bcl-2 and c-myc

1994 • 46 citations

Bax expression and growth behavior of basal cell carcinomas

2002 • 43 citations

Immune‐associated cells in basal cell carcinomas of skin

1996 • 33 citations

How Specific Is the TUNEL Reaction?

2002 • 33 citations

Successful Treatment of Multiple Superficial Basal Cell Carcinomas with Topical Imiquimod: Case Report and Review of the Literature

2002 • 33 citations

Value of p53 protein in biological behavior of basal cell carcinoma and in normal epithelia adjacent to carcinomas

2000 • 32 citations

p53 modulation of Fas/Apo-1 mediated apoptosis in a human renal cell carcinoma cell line.

1998 • 26 citations

Laminin receptor in lymph node negative breast carcinoma

1999 • 24 citations

Interaction between bcl-2 and P53 in neoplastic progression of basal cell carcinoma of the head and neck.

2002 • 24 citations

Antitumor Actions of Interferons

1987 • 21 citations

Enhancement of Natural Killer Cell Activation and Antibody-Dependent Cellular Cytotoxicity by Interferon-αand Interleukin-12 in Vaginal Mucosae SIV_mac251-InfectedMacaca fascicularis

2002 • 16 citations

Expression of the pro‐apoptotic caspase 3/CPP32 in cutaneous basal and squamous cell carcinomas

2000 • 16 citations

Transplantation of Human Basal Cell Carcinoma to C57/BALB/C bg^J/bg^J‐nu/nu (Beige‐Nude) Mouse

1988 • 15 citations